Remote EEG Device for Identification of Risk for Neonatal Seizures

Mayo Clinic

Overview

The purpose of this study is to see if the use of wireless brain wave monitoring can be helpful for newborns and help their medical providers identify seizures earlier and to monitor for the risk for seizures.

Our goals are to evaluate the effectiveness of the Epilog device in identification of neonates who are at risk for seizures and need formal EEG monitoring or cooling. The current process for these patients would be transfer from Rochester Methodist Hospital to the St. Mary's level 3 NICU for EEG monitoring. Given that in case of neonatal encephalopathy, there is 6-hour window in which to make the critical decision of whether to initiate therapeutic hypothermia or not, rapid access to EEG data is crucial. We would like to perform a pilot study on use of wireless EEG technology in neonates with mild neonatal encephalopathy and neonates with spells to see if this device can be used to determine the risk for neonatal seizure and need for escalation of care and full scalp EEG.

Study Type

INTERVENTIONAL

Allocation

Purpose

DEVICE_FEASIBILITY

Masking

NONE

Conditions

Neonatal Encephalopathy

Interventions

Epilog deviceDEVICE

Pilot the use of wireless EEG technology in neonates with mild neonatal encephalopathy and neonates with spells to see if this device can be used to determine the risk for neonatal seizure and need for escalation of care and full scalp EEG

Eligibility

Sex: ALLMax age: 30 Days

Medical Language ↔ Plain English

Inclusion Criteria: * Age 28 days old or less (postnatal age) * Neonatal encephalopathy as judged by clinical team or symptoms concerning for subtle seizures * Patient currently in level 1 newborn nursery or level 2 or 3 NICU Exclusion Criteria: * Medical comorbidity which would result in prolonged need for sedation * Prolonged EEG monitoring is medically indicated

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

Evaluate the effectiveness of the Epilog device in identification of neonates who are at risk for seizures and need formal EEG monitoring or cooling

Total number of neonates that Epilog device identifies as requiring formal EEG monitoring

Time frame: Approximately 2 to 72 hours

Evaluate time to formal long-term EEG monitoring in neonates monitored with the Epilog device compared to a historical control cohort of neonates undergoing EEG evaluation.

Time from initiation of monitoring with Epilog device to monitoring completion or conversion to formal prolonged EEG monitoring.

Time frame: Approximately 2 to 72 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.